⌘K

Home/Filings/4/0001415889-25-009654

4//SEC Filing

Corcoran Gavin 4

Accession 0001415889-25-009654

CIK 0001660334other

View on SEC.gov Company Profile

Filed

Apr 1, 8:00 PM ET

Accepted

Apr 2, 4:32 PM ET

Size

5.6 KB

Accession

0001415889-25-009654

Insider Transaction Report

Form 4

Period: 2025-03-31

Verrica Pharmaceuticals Inc.VRCA

Director

Transactions

Award
Stock Option (right to buy)
2025-03-31+17,502→ 17,502 total
Exercise: $0.44Exp: 2035-03-31→ Common Stock (17,502 underlying)

Footnotes (1)

[F1]1/3rd of the total shares subject to the option shall vest on March 31, 2026, and 1/36th of the total shares subject to the option shall vest in 24 monthly installments thereafter, subject to the Reporting Person's continuous service through such vesting date.

Documents

1 file

4
form4-04022025_080448.xmlPrimary

Issuer

Verrica Pharmaceuticals Inc.

CIK 0001660334

Entity typeother

Related Parties

1

filerCIK 0001745995

Filing Metadata

Form type: 4
Filed: Apr 1, 8:00 PM ET
Accepted: Apr 2, 4:32 PM ET
Size: 5.6 KB

View on SEC.gov